Speaker(s): 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Practice and promote clinical evaluation for identifying the cognitively vulnerable and which patients would be most appropriate for evaluation with biomakers for neurodegenerative causes of cognitive disorders.

2. Counsel patients and families and colleagues on the limits and uses of biomarkers for evaluation and management of cognitive disorders.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Chichun Emily Sun DO and Karen Tillotson, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session:

None.